What is the most important thing that I should know about Ariphrenz?
Ariphrenz is not approved in elderly patients with dementia as it may increase the risk of causing death. Dementia is a brain disorder that affects the ability to remember, think clearly, communicate, and perform daily activities. This may further cause changes in mood and personality. Furthermore, patients with depression should be closely monitored when being given Ariphrenz, as they can develop suicidal tendencies.